Orion Biotech Opportunities Corp.

Overview

• IndustryBlank Checks¹
• HeadquartersNew York, New York¹
• Incorporated inCayman Islands³
• Business addressOne Vanderbilt Avenue, 26Th Floor, New York, Ny 10017³
• Filer category, Emerging growth company³

See how the biggest companies compare on our leaderboards

Corporate structure

Orion Biotech Opportunities Corp. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Orion Biotech Opportunities Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

Leadership

Who has led Orion Biotech Opportunities Corp., and when. Pick a name to see everywhere that person has worked.

• Chief financial officerMark Kayal May 12, 2021 to May 12, 2021⁷

Timeline

1. Apr 24, 20238-K Other events¹⁰
2. Dec 20, 20218-K Earlier financial statements no longer reliable¹¹

Filings

21 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 2 major events, 4 insider forms, 5 large holders, 3 other. The latest 20:

1. Feb 14, 2024SC 13G/A 683 CAPITAL MANAGEMENT, LLC EDGAR
2. May 18, 20234 EDGAR
3. May 18, 20234 EDGAR
4. May 18, 20234 EDGAR
5. May 18, 20234 EDGAR
6. May 11, 202315-12G EDGAR
7. May 1, 202325 EDGAR
8. Apr 24, 20238-K CURRENT REPORT EDGAR
9. Mar 29, 202310-K ANNUAL REPORT EDGAR
10. Feb 14, 2023SC 13G/A EDGAR
11. Nov 10, 202210-Q QUARTERLY REPORT EDGAR
12. Aug 12, 202210-Q QUARTERLY REPORT EDGAR
13. May 11, 202210-Q QUARTERLY REPORT EDGAR
14. Mar 24, 202210-K ANNUAL REPORT EDGAR
15. Feb 14, 2022SC 13G EDGAR
16. Feb 14, 2022SC 13G EDGAR
17. Dec 20, 202110-Q/A AMENDMENT NO. 1 TO FORM 10-Q EDGAR
18. Dec 20, 2021425 CURRENT REPORT EDGAR
19. Dec 20, 20218-K CURRENT REPORT EDGAR
20. Nov 12, 202110-Q QUARTERLY REPORT EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• 683 Capital Management, LLCSC 13G/A, 1 filing Feb 14, 2024¹²
• Orion Sponsor Holdings, LLCSC 13G/A, 2 filings Feb 14, 2022 to Feb 14, 2023¹³
• FIR TREE CAPITAL MANAGEMENT LPSC 13G, 1 filing Feb 14, 2022¹⁴
• GERALD D. HOSIER REVOCABLE TRUSTSC 13G, 1 filing Oct 15, 2021¹⁵

SEC filer profile

How Orion Biotech Opportunities Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGAROrion Biotech Opportunities Corp.¹
• CIK0001847416
• Filer status<br>emerging growth company¹
• Incorporated inCayman Islands¹
• Fiscal year endsDecember 31¹
• Industry code (SIC)6770 Blank Checks¹
• SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance¹
• Business addressOne Vanderbilt Avenue, 26Th Floor, New York, NY 10017¹
• Phone212-303-7822¹
• Public float$194.7M as of Jun 30, 2022²
• On EDGAR sinceFeb 25, 2021¹
• Filings50 in all: 3 (7), 10-Q (6), 4 (5), 8-K (5), SC 13G (5), CORRESP (4), S-1/A (3), 10-K (2)¹
  All 19 form types

  SC 13G/A (2), UPLOAD (2), 10-Q/A (1), 15-12G (1), 25 (1), 424B4 (1), 425 (1), 8-A12B (1), CERT (1), EFFECT (1), S-1 (1)

• Latest filingsAnnual report (10-K) Mar 29, 2023
  Quarterly report (10-Q) Nov 10, 2022
  Latest 8-K (8-K) Apr 24, 2023